Raymond James & Associates’s Cabot Corp CBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.55M | Buy |
40,741
+7,999
| +24% | +$797K | ﹤0.01% | 1718 |
|
|
2024
Q2 | $3.01M | Sell |
32,742
-1,940
| -6% | -$188K | ﹤0.01% | 1920 |
|
|
2024
Q1 | $3.2M | Sell |
34,682
-7,421
| -18% | -$603K | ﹤0.01% | 1873 |
|
|
2023
Q4 | $3.52M | Buy |
42,103
+225
| +0.5% | +$16.7K | ﹤0.01% | 1754 |
|
|
2023
Q3 | $2.9M | Buy |
41,878
+1,986
| +5% | +$138K | ﹤0.01% | 1796 |
|
|
2023
Q2 | $2.67M | Sell |
39,892
-7,457
| -16% | -$531K | ﹤0.01% | 1881 |
|
|
2023
Q1 | $3.63M | Sell |
47,349
-193
| -0.4% | -$14.5K | ﹤0.01% | 1683 |
|
|
2022
Q4 | $3.18M | Buy |
47,542
+14,216
| +43% | +$993K | ﹤0.01% | 1713 |
|
|
2022
Q3 | $2.13M | Buy |
33,326
+3,977
| +14% | +$280K | ﹤0.01% | 1923 |
|
|
2022
Q2 | $1.87M | Sell |
29,349
-3,785
| -11% | -$259K | ﹤0.01% | 2024 |
|
|
2022
Q1 | $2.27M | Buy |
33,134
+2,521
| +8% | +$166K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $1.72M | Buy |
30,613
+1,639
| +6% | +$90.1K | ﹤0.01% | 2274 |
|
|
2021
Q3 | $1.45M | Sell |
28,974
-4,703
| -14% | -$251K | ﹤0.01% | 2328 |
|
|
2021
Q2 | $1.92M | Buy |
33,677
+12,695
| +61% | +$746K | ﹤0.01% | 2131 |
|
|
2021
Q1 | $1.1M | Buy |
20,982
+10,609
| +102% | +$523K | ﹤0.01% | 2441 |
|
|
2020
Q4 | $466K | Sell |
10,373
-4,537
| -30% | -$188K | ﹤0.01% | 2860 |
|
|
2020
Q3 | $537K | Sell |
14,910
-2,355
| -14% | -$89.5K | ﹤0.01% | 2564 |
|
|
2020
Q2 | $640K | Sell |
17,265
-482
| -3% | -$16.1K | ﹤0.01% | 2435 |
|
|
2020
Q1 | $464K | Buy |
17,747
+3,105
| +21% | +$118K | ﹤0.01% | 2468 |
|
|
2019
Q4 | $696K | Sell |
14,642
-1,489
| -9% | -$69.1K | ﹤0.01% | 2501 |
|
|
2019
Q3 | $731K | Buy |
16,131
+2,952
| +22% | +$127K | ﹤0.01% | 2386 |
|
|
2019
Q2 | $629K | Sell |
13,179
-522
| -4% | -$23.5K | ﹤0.01% | 2512 |
|
|
2019
Q1 | $570K | Buy |
13,701
+385
| +3% | +$17.3K | ﹤0.01% | 2565 |
|
|
2018
Q4 | $572K | Buy |
13,316
+517
| +4% | +$25.8K | ﹤0.01% | 2460 |
|
|
2018
Q3 | $803K | Sell |
12,799
-4,582
| -26% | -$295K | ﹤0.01% | 2392 |
|
|
2018
Q2 | $1.07M | Buy |
17,381
+12,698
| +271% | +$752K | ﹤0.01% | 2158 |
|
|
2018
Q1 | $261K | Buy |
+4,683
| New | +$295K | ﹤0.01% | 2977 |
|
|
2017
Q4 | – | Sell |
-3,907
| Closed | -$218K | – | 3439 |
|
|
2017
Q3 | $218K | Sell |
3,907
-72
| -2% | -$3.85K | ﹤0.01% | 2988 |
|
|
2017
Q2 | $213K | Buy |
+3,979
| New | +$218K | ﹤0.01% | 2941 |
|
|
2016
Q4 | – | Sell |
-22,115
| Closed | -$1.16M | – | 3255 |
|
|
2016
Q3 | $1.16M | Buy |
22,115
+2,447
| +12% | +$121K | ﹤0.01% | 1790 |
|
|
2016
Q2 | $898K | Sell |
19,668
-6,375
| -24% | -$297K | ﹤0.01% | 1795 |
|
|
2016
Q1 | $1.26M | Sell |
26,043
-22,517
| -46% | -$969K | ﹤0.01% | 1545 |
|
|
2015
Q4 | $1.99M | Sell |
48,560
-12,482
| -20% | -$494K | 0.01% | 1268 |
|
|
2015
Q3 | $1.93M | Buy |
61,042
+7,245
| +13% | +$251K | 0.01% | 1239 |
|
|
2015
Q2 | $2.01M | Buy |
53,797
+18,711
| +53% | +$807K | 0.01% | 1314 |
|
|
2015
Q1 | $1.58M | Buy |
35,086
+10,975
| +46% | +$485K | 0.01% | 1386 |
|
|
2014
Q4 | $1.06M | Buy |
24,111
+5,831
| +32% | +$263K | 0.01% | 1539 |
|
|
2014
Q3 | $928K | Buy |
18,280
+3,352
| +22% | +$184K | 0.01% | 1541 |
|
|
2014
Q2 | $866K | Buy |
+14,928
| New | +$870K | 0.01% | 1579 |
|
Other funds holding CBT
SCM
Raymond James & Associates's CBT Position: Q3 2024 in Review
Raymond James & Associates increased its Cabot Corp (CBT) stake by 24% in Q3 2024, buying an estimated $797K and bringing the position to 40,741 shares worth $4.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.
Raymond James & Associates first reported a position in CBT in Q2 2014 and has held it in 39 quarters since. 407 funds tracked by Wall St. Rank hold CBT as of Q3 2024.
- Raymond James & Associates held 40,741 shares of Cabot Corp worth $4.55M as of Q3 2024.
- Raymond James & Associates bought 7,999 Cabot Corp shares in Q3 2024, an estimated $797K.
- Cabot Corp made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1718 holding.
- Raymond James & Associates first reported a position in Cabot Corp in Q2 2014 and has held it in 39 quarters since.
- 407 funds tracked by Wall St. Rank held Cabot Corp as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.